Can gut bacteria help rebuild immunity after stem cell transplants?

NCT ID NCT07755319

First seen Aug 10, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This trial explores whether transplanting gut bacteria from healthy donors can help restore the immune system in people who have weak immunity after a stem cell transplant. The study first observes immune recovery in patients to identify those with severe deficiency, then gives a short course of specially selected fecal microbiota capsules to a small group. The goal is to see if this approach is safe and feasible, and whether it can improve antibody production.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fecal microbiota transplantation (FMT) capsules made from healthy donor stool, rich in propionate- and butyrate-producing bacteria.
What this could lead to
If successful, this could offer a new way to boost immune recovery after stem cell transplants, potentially reducing infections and other complications.
What could go wrong
This is an early-phase trial with a small number of participants, so results may not be conclusive. There are also risks of side effects, including infections or worsening of graft-versus-host disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, 215006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.